F045 Unraveling Frontal Fibrosing Alopecia: Current Landscape and Challenges
DESCRIPTION
Frontal fibrosing alopecia (FFA) is a relatively newly described disease which is now commonly seen in medical dermatology and hair disease clinics. This session will review the current landscape of what we know about frontal fibrosing alopecia, the role of cosmetic procedures and sunscreens in FFA patients as well as new technologies to both study, treat and monitor this disease. Treatment algorithms for patients with newly diagnosed and those with extensive burnt out disease will be discussed. The session will conclude with case presentations by hair disease experts.
LEARNING OBJECTIVES
Describe and implement treatments for FFA.
Select what cosmetic procedures are most appropriate for the FFA patient
Summarize what we know about FFA, sunscreens, future directions with Jak inhibitors and more
SCHEDULE
3:30 PM
Opening
Isabella Doche, MD, PhD, IFAAD
3:32 PM
Back to the future: from pathogenesis to future insights
Maria K. Hordinsky, MD, FAAD
3:44 PM
Decoding clinical features
Isabella Doche, MD, PhD, IFAAD
3:56 PM
FFA in dark-skinned patients
Ncoza Dlova
4:08 PM
Tips to better approach and follow-up FFA patients
David Saceda-Corralo, MD, PhD
4:20 PM
Q&A
4:26 PM
Cosmetics procedures in FFA: what to do and not to do
Ronda S. Farah, MD, FAAD
4:38 PM
A critical view on the role of sunscreens
Maria F. R. Gavazzoni Dias, MD, IFAAD
4:50 PM
A look into the future: JAK-inhibitors and new drugs
Maryanne Makredes Senna, MD, FAAD
5:02 PM
Q&A
5:08 PM
Cases for discussion with panelists
Wilma Fowler Bergfeld, MD, FAAD, Elise A. Olsen, MD, FAAD, Jerry Shapiro, MD, FAAD, Antonella Tosti, MD
5:28 PM
Closing
Maria K. Hordinsky, MD, FAAD
DIRECTOR
Maria K. Hordinsky, MD, FAAD
CO-DIRECTOR
Isabella Doche, MD, PhD, IFAAD
SPEAKERS
Wilma Fowler Bergfeld, MD, FAAD
Ncoza Dlova
Ronda S. Farah, MD, FAAD
Maria F. R. Gavazzoni Dias, MD, IFAAD
Maryanne Makredes Senna, MD, FAAD
Elise A. Olsen, MD, FAAD
David Saceda-Corralo, MD, PhD
Jerry Shapiro, MD, FAAD
Antonella Tosti, MD
HANDOUTS
DISCLOSURES
Wilma Fowler Bergfeld, MD, FAAD
No financial relationships exist with ineligible companies.
Ncoza Dlova
No financial relationships exist with ineligible companies.
Isabella Doche, MD, PhD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Speaker/Faculty Education(Fees); Cantabria Labs – Speaker/Faculty Education(Fees); Fotofinder – Other(Equipment); GlaxoSmithKline Immunology – Speaker/Faculty Education(Fees); L'Oreal – Speaker/Faculty Education(Fees); Mantecorp – Consultant (1099 relationship)(Fees); Panalab – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker/Faculty Education(Fees); Pierre Fabre – Speaker/Faculty Education(Fees); TheraSkin Farmacêutica – Consultant (1099 relationship)(Fees);
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);
Maria F. R. Gavazzoni Dias, MD, IFAAD
No financial relationships exist with ineligible companies.
Maria K. Hordinsky, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Cassiopea – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); McGraw-Hill Companies – Other(Fees); National Alopecia Areata Foundation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees); VeraDermics Inc. – Investigator(Grants/Research Funding);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Fees); Cassiopia – Advisory Board(Fees); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); Concert Pharmaceuticals – Consultant(Fees); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Department Of Health and Human Services; Division of Vaccine Injury Compensation – Independent Contractor(Fees); Eli Lilly – Speaker(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Follica – Investigator(Equipment); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Other(Grants/Research Funding), Speaker(Fees); Q32 Bio Inc. – Investigator(Grants/Research Funding); Santiste Medical – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);
Elise A. Olsen, MD, FAAD
Canfield Scientific, Inc. – Consultant(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Equillium, Inc. – Consultant (1099 relationship)(Honoraria); Kyowa Kirin – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
David Saceda-Corralo, MD, PhD
Cantabria Labs – Advisory Board(Fees), Investigator(No Compensation Received); Concert Pharmaceuticals – Investigator(No Compensation Received); Eli Lilly and Company – Advisory Board(Fees), Speaker(Honoraria); ISDIN – Advisory Board(Fees), Speaker(Fees); L'Oreal – Advisory Board(Fees), Speaker(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Residency/Fellowship Program Funding), Speaker(Fees);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);